Meeting
2021 ASCO Quality Care Symposium
Trends in end-of- life (EOL) systemic oncologic treatment in contemporary clinical practice: Insights from real-world data.
Authors
Maureen Canavan
Yale School of Medicine, New Haven, CT
Maureen Canavan, Xiaoliang Wang, Mustafa Ascha, Rebecca A. Miksad, Timothy N Showalter, Gregory Sampang Calip, Cary Philip Gross, Kerin B. Adelson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care
Track
Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Quality Improvement Research and Implementation Science
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 253)
DOI
10.1200/JCO.2020.39.28_suppl.253
Abstract #
253
Poster Bd #
D6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The association between systemic anticancer therapy (SACT) at the end of life (EOL) and acute care use among patients treated at oncology practices participating in the Oncology Care Model (OCM).
First Author: Maureen Canavan
Poster
2021 ASCO Quality Care Symposium
Differences by race in systemic oncologic end-of-life (EOL) care among patients with cancer.
First Author: Kerin B. Adelson
Poster
2020 ASCO Quality Care Symposium
Real-world patterns of chemotherapy and immunotherapy utilization at end of life in a large community oncology network.
First Author: Stephen Matthew Schleicher
Poster
2024 ASCO Annual Meeting
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
First Author: Kerin B. Adelson